At Courage Against Cancer (CAC), we believe cancer patients deserve evidence-based answers to the central question driving this article: What are qualified oncologists and researchers actually saying about fenbendazole in 2026? The short answer is nuanced — scientific interest exists, but formal clinical evidence remains limited.
